faculty

Projects

Home / Projects / Prepare-NS Field Testing and Psychometric Evaluation of the Nephrotic Syndrome Swelling Impact Measures (NS-SIM) - Patient-Reported Outcome (PRO) Measure & Observer-Reported Outcome (ObsRO)

Prepare-NS Field Testing and Psychometric Evaluation of the Nephrotic Syndrome Swelling Impact Measures (NS-SIM) - Patient-Reported Outcome (PRO) Measure & Observer-Reported Outcome (ObsRO)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2028

Project Lead

Dr. Arpana Iyengar

Authors

Dr. Anil Vasudevan, Dr. Niveditha Kamath & Dr. Soumya Reddy

Project Status

ongoing

Project Type

FDA-funded